Total Voting Rights
Summary by AI BETAClose X
Ninety One plc Ninety One Limited
Incorporated in England and Wales Incorporated in the Republic of South Africa
Registration number 12245293 Registration number 2019/526481/06
Date of registration: 4 October 2019 Date of registration: 18 October 2019
LSE share code: N91 JSE share code: NY1
JSE share code: N91 ISIN: ZAE000282356
ISIN: GB00BJHPLV88
LEI: 549300G0TJCT3K15ZG14
The following information is released in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R and 5.6.1AR.
Ninety One plc (the 'Company') Total Voting Rights
The Company repurchased its own ordinary shares during August and September 2025. The Company now provides the information required in accordance with DTR 5.6.1R and 5.6.1AR.
As at 29 August 2025, the Company's issued ordinary share capital consisted of 628,480,526 ordinary shares of £0.0001 each, carrying one voting right per share. The Company does not hold any shares in Treasury, therefore, the total number of shares with voting rights in the Company as at 29 August 2025 was 628,480,526.
As at 30 September 2025, the Company's issued ordinary share capital consisted of 628,010,898 ordinary shares of £0.0001 each, carrying one voting right per share. The Company does not hold any shares in Treasury. Therefore, the total number of shares with voting rights in the Company as at 30 September 2025 was 628,010,898.
Shareholders should use the above figures as the denominator for the purposes of the FCA's Disclosure Guidance and Transparency Rules.
Date of release: 07 October 2025
JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 18 minutes ago JPMorgan Emerging Markets Growth & Income plc
- 20 minutes ago National Grid
- 56 minutes ago City of London Investment Group
- 1 hour ago BioPharma Credit
- 1 hour ago BioPharma Credit